![AstraZeneca](https://www.adcreviews.com/wp-content/uploads/2022/11/AstraZeneca-240x135.jpg)
AstraZeneca abandons U.S. application for COVID-19 vaccine, halts development of multiple drugs
On November 10, when AstraZeneca announced its third-quarter 2022 results, it also announced that it would not submit a listing application for the new crown